Oric Pharmaceuticals | 10-Q:2024財年二季報
Oric Pharmaceuticals | 8-K:ORIC 製藥公佈2024年第二季度財務業績和運營最新情況
Oric Pharmaceuticals | 4:持股變動聲明-董事 Kunkel Lori Anne
Oric Pharmaceuticals | 4:持股變動聲明-董事 You Angie
Oric Pharmaceuticals | 4:持股變動聲明-董事 Hoerter Steven L.
Oric Pharmaceuticals | 4:持股變動聲明-董事 Dier Mardi
Oric Pharmaceuticals | 4:持股變動聲明-董事 Heyman Richard A.
Oric Pharmaceuticals | 8-K:重大事件
Oric Pharmaceuticals | 4:持股變動聲明-董事 Kunkel Lori Anne
Oric Pharmaceuticals | 10-Q:2024財年一季報
Oric Pharmaceuticals | 8-K:ORIC 製藥公佈2024年第一季度財務業績和運營最新情況
Oric Pharmaceuticals | ARS:年度報告
Oric Pharmaceuticals | DEFA14A:其他
Oric Pharmaceuticals | DEF 14A:股東委託書決議
Oric Pharmaceuticals | S-8:員工福利計劃證券登記
Oric Pharmaceuticals | 8-K:重大事件
Oric Pharmaceuticals | S-3ASR:“知名成熟發行人”證券註冊聲明
Oric Pharmaceuticals | 10-K:2023財年年報
Oric Pharmaceuticals | 8-K:ORIC Pharmicals公佈2023年第四季度和全年財務業績和運營最新情況
Oric Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(7.562%),Abigail P. Johnson(7.562%)
暫無數據
暫無數據